European C21 BioVentures
'Aberrations In Value' Can Help Biotech Pull In Global Funding
By Brady Huggett
Monday, March 28, 2005
LONDON - Jonathan Kil, president and CEO of Sound Pharmaceuticals Inc., is looking for a considerable first round of funding - as much as $40 million, although that might be done in tranches, with a first closing for $10 million.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.